Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Ruriko Yokokawa"'
Autor:
Yoshiyuki Tanaka, Ruriko Yokokawa, Han Shi Rong, Hiroyuki Kishino, Jon E. Stek, Margaret Nelson, Jody Lawrence
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 13, Iss 6, Pp 1352-1358 (2017)
Rotavirus is the leading cause of severe acute gastroenteritis in infants and young children. Most children are infected with rotavirus, and the health and economic burdens of rotavirus gastroenteritis on healthcare systems and families are considera
Externí odkaz:
https://doaj.org/article/40971ff0a49e4bff843b6461976b73a9
Autor:
Miyuki Sawata, Shi Rong Han, Yoshiyuki Tanaka, Shinya Murata, Hiroshige Mikamo, Ruriko Yokokawa, Akira Wakana, Yuka Yamagishi
Publikováno v:
Vaccine. 37:1651-1658
The quadrivalent (q) human papillomavirus (HPV) vaccine protects against infection and disease related to HPV types 6, 11, 16, and 18. We report efficacy, immunogenicity, and safety of qHPV vaccine in a Phase 3 study in Japanese men.In this randomize
Autor:
Jon E. Stek, Hiroyuki Kishino, Jody Lawrence, Han Shi Rong, Margaret Nelson, Ruriko Yokokawa, Yoshiyuki Tanaka
Publikováno v:
Human Vaccines & Immunotherapeutics
Rotavirus is the leading cause of severe acute gastroenteritis in infants and young children. Most children are infected with rotavirus, and the health and economic burdens of rotavirus gastroenteritis on healthcare systems and families are considera
Autor:
Shinya Murata, Kou Yamanaka, Ruriko Yokokawa, Jun Hayakawa, Akira Wakana, Yuzuru Takeuchi, Masashige Yoshida, Yoshiyuki Tanaka, Miyuki Sawata
Publikováno v:
Japanese journal of infectious diseases. 72(5)
Human papillomavirus (HPV)-associated disease is common among men with HPV infection. A quadrivalent HPV (qHPV) vaccine has demonstrated 85.9% efficacy against HPV6/11/16/18-related, persistent (≥ 6 month) infection in a study of Japanese men aged
Autor:
Soichi Arakawa, Norihiro Aoyama, Ruriko Yokokawa, Asako Sato, Go Fujimoto, Mitsuru Yasuda, Kazuya Kawahara, Elizabeth G. Rhee, Motoshi Kawahara, Tomoko Yoshinari
Publikováno v:
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy. 25(2)
We report efficacy and safety results for a combination of a novel cephalosporin class antibiotic and a β-Lactamase inhibitor, tazobactam/ceftolozane (1:2) at a dose of 1.5 g intravenously every 8 h in Japanese patients with uncomplicated pyelonephr